These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 1694023

  • 1. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.
    Cairo MS, Mauss D, Kommareddy S, Norris K, van de Ven C, Modanlou H.
    Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023
    [Abstract] [Full Text] [Related]

  • 2. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 3. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.
    Cairo MS, Plunkett JM, Mauss D, Van de ven C.
    Blood; 1990 Nov 01; 76(9):1788-94. PubMed ID: 1699622
    [Abstract] [Full Text] [Related]

  • 4. Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis.
    Cairo MS, Plunkett JM, Nguyen A, van de Ven C.
    Blood; 1992 Jul 01; 80(1):96-101. PubMed ID: 1377057
    [Abstract] [Full Text] [Related]

  • 5. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS, Mauss D, Plunkett JM, Gillis S, van de Ven C.
    Pediatr Res; 1991 May 01; 29(5):504-9. PubMed ID: 1896256
    [Abstract] [Full Text] [Related]

  • 6. Sequential administration of interleukin-6 and granulocyte-colony stimulating factor in newborn rats: modulation of newborn granulopoiesis and thrombopoiesis.
    Cairo MS, Plunkett JM, Nguyen A, Clark S, van de Ven C.
    Pediatr Res; 1991 Dec 01; 30(6):554-9. PubMed ID: 1725208
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and pharmacodynamics of recombinant human granulocyte-colony stimulating factor after intravenous and subcutaneous administration in the rat.
    Tanaka H, Okada Y, Kawagishi M, Tokiwa T.
    J Pharmacol Exp Ther; 1989 Dec 01; 251(3):1199-203. PubMed ID: 2481032
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats.
    Chang M, Williams A, Ishizawa L, Knoppel A, van de Ven C, Cairo MS.
    Blood Cells Mol Dis; 1996 Dec 01; 22(1):57-67. PubMed ID: 8807086
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K, Obuchi M, Watanabe M, Kusaka M, Seki M.
    Oncol Res; 1995 Dec 01; 7(3-4):165-71. PubMed ID: 8555650
    [Abstract] [Full Text] [Related]

  • 15. Review of G-CSF and GM-CSF. Effects on neonatal neutrophil kinetics.
    Cairo MS.
    Am J Pediatr Hematol Oncol; 1989 Dec 01; 11(2):238-44. PubMed ID: 2473663
    [Abstract] [Full Text] [Related]

  • 16. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor.
    Cairo MS, van de Ven C, Mauss D, Kommareddy S, Norris K, Sheikh K, Modanlou H.
    Biol Neonate; 1991 Dec 01; 59(1):13-21. PubMed ID: 1707685
    [Abstract] [Full Text] [Related]

  • 17. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H, Okano A, Suzuki C, Konishi A, Akiyama Y, Ishibashi T, Ozawa K, Asano S.
    Transplantation; 1995 Jun 15; 59(11):1596-600. PubMed ID: 7539959
    [Abstract] [Full Text] [Related]

  • 18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.